BAC and Octapharma Extend Recombinant Factor IX Collaboration

News   Nov 04, 2009

 
BAC and Octapharma Extend Recombinant Factor IX Collaboration
 
 
 

RELATED ARTICLES

PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug Discovery

News

Investment to fund expansion of operations and progression of drug target pipeline.

READ MORE

Computation and Chemistry Combine to Create World-First Auxetic Protein

News

A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.

READ MORE

Robots Grow Mini-Organs From Human Stem Cells

News

A robotic approach to mass-producing organoids could accelerate regenerative medicine research and drug discovery.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE